SPC

To ensure the continued development of medicinal products which are the result of enormous R&D costs the supplementary protection certificate (‘SPC’) was introduced into EU law in 1993 with the entry…

According to Spanish law, the decisions handed down by the Spanish Patents and Trademarks Office ("SPTO") in relation to applications for Supplementary Protection Certificates ("SPCs") may be…

Case reported and summarised by Gregory Bacon, Bristows LLP The UK does not operate a system of automatically staying proceedings which concern validity of a European patent where there are ongoing…

The European Commission has taken the first step towards creating a European Supplementary Protection Certificate (SPC). A Call for Tender for a ‘Study on the legal aspects of the supplementary…

One of the legacies that the year we are about to leave behind will leave us is the Judgment of 6 October 2015 handed down by the Court of Justice of the European Union ("CJEU") in Case C-471/14…

The lack of provisions on Supplementary Protection Certificates (SPCs) is seen as a major flaw in the new Unitary Patent (UP) system. Initiatives have been taken to address this issue and recently…

In the Sanofi v. Teva ruling of 10 July 2014, the Court of Milan clarified the test for abuse of process, and denied an award of damages allegedly caused by the issue of a preliminary injunction…

The legendary deficient regulation of supplementary protection certificates ("SPCs") has caused the Spanish Patent and Trademark Office (the "SPTO") and Spanish Courts to struggle as to whether or…

In the aftermath of the CJEU decisions Eli Lilly/Medeva and Actavis/Georgetown II, the Swiss Federal Institute of Intellectual Property proposes changes in its SPC granting practice. One hot topic in…